Cita APA

Redana, S., Donadio, M., Nolè, F., Jacomuzzi, M. E., Beano, A., Martinello, R., . . . Montemurro, F. (2010). Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: A retrospective comparison. BioMed Central.

Chicago Style Citation

Redana, Stefania, et al. Trastuzumab With Either Docetaxel or Vinorelbine As First-line Treatment for Patients With HER2-positive Advanced Breast Cancer: A Retrospective Comparison. BioMed Central, 2010.

Cita MLA

Redana, Stefania, et al. Trastuzumab With Either Docetaxel or Vinorelbine As First-line Treatment for Patients With HER2-positive Advanced Breast Cancer: A Retrospective Comparison. BioMed Central, 2010.